Sie sind auf Seite 1von 7



Angsana J, et al. (2015). Syndecan Modulates the motility and resolution responses of

Antmant EM, Braunwald E. (2008). ST-Elevation Myocardial Infarction: Pathology,

Pathophysiology, and Clinical Features. Dalam: Braunwald E.ed. Braunwald’s Heart Disease 8th
ed. Philadelphia: Saunders Elsevie. Pp: 1207-31

Augustin, Hellmut G, et al. (2009). Control of Vascular Morphogenesis and Homeostasis

Through the Angiopoietin-Tie System. Nature Reviews Molecular Cell Biology. 10: 165-77

Barton WA, Tzvetkova D, Nikolov DB, (2006). Structure of the angiopoetin-2 receptor binding
domain and identification of surface involved in Tie-2 recognition. Structure, 15, 825-832

Bates DO, Hillman NJ, Williams B, Neal CR and Pocock TM. (2002). Regulation of
microvascular permeability by vascular endothelial growth factors. J Anat 200: 581-597.
Borissoff J, et al. (2011). The Hemostatic System as a Modulator of Atherosclerosis, n engl j
med 364;18

Brindle, Nicholas P.J., Sharinen, Pipsa, Alitalo, Kari. (2006). Signalling and Functions of
Angiopoietin-1 in Vascular Protection. Circ Res. 98(8) : 1014-23

Burke AP, Virmani R, Galis Z, Haudenschild CC, Muller JE. (2003). 34th Bethesda Conference:
Task force #2—What is the pathologic basis for new atherosclerosis imaging techniques? J Am
Coll Cardiol ; 41: 1874–1886.

Ceponiene I, et al. (2014). Association of major cardiovascular risk factors with the development
of acute coronary syndrome in Lithuania, European Heart Journal Supplements ), (Supplement
A), A80–A83

Chiodelli, P, et al. (2015). Heparin/Heparan Sulfate Proteoglycans Glycomic Interactome in

Angiogenesis: Biological Implications and Therapeutical Use. Molecules 20 : 6342-6388

Chong, Aun Y., et al. (2004). Plasma Angiopoietin-1, Angiopoietin-2, and Angiopoietin
Receptor Tie-2 Levels in Congestive Heart Failure. Journal of the American College of
Cardiology vol. 43

Christian W, et al. (2014). Acute Coronary Syndromes: Pathophysiology, Diagnosis and Risk

David, Sascha, et al. (2009). Circulating Angiopoietin-2 in Essential Hypertension : Relation to

Atherosclerosis, Vascular Inflammation, and Treatment with Olmesartan/Pravastatin. Journal of
Hypertension 27:1641-1647


David, Sascha, et al. (2010). Circulating Angiopoietin-2 Levels Increase with Progress of CKD.
Nephrol Dial Transplant 25: 2571–2579

Davis S, Aldrich TH, Jones PF, Acheson A, Compton DL, Jain V, et a. (1996). Isolation of
angiopoetin-1, a ligand for the TIE2 receptor by secretion-trap expression cloning. Cell, 87,

Davy Vanhoutte et al. (2007). Increase Expression Of Syndecan-1 Protects Against Cardiac
Dilatation And Dysfunction After Myocardial Infarction

Deuse T, Peter C, Fedak PW, Doyle T, Reichenspurner H, Zimmermann WH, Eschenhagen T,

Stein W, Wu JC, Robbins RC and Schrepfer S. (2009). Hepatocyte growth factor or vascular
endothelial growth factor gene transfer maximizes mesenchymal stem cell-based myocardial
salvage after acute myocardial infarction. Circulation 120 (Suppl 11): S247-S254

Dharma S, et al. (2012). Acute Myocardial Infarction System of Care in The Third World, Neth
Heart J 20:254-259

Dimmeler, Stefanie, Zeiher, Andreas M.(2013). Akt Takes Center Stage in Angiogenesis
Signalling. Circ Res 2000; 86:4-5

Dreyfuss J L. et al. (2009). Heparan Sulfate Proteoglycans: Structure, Protein Interactions And
Cell Signaling. Anais da Academia Brasileira de Ciências 81(3): 409-429

Eklund & Saharinen. (2013) . Angiopoietin signaling in the vasculature. Exp Cell Res.15;319(9)

Eltzschig HK, Carmeliet P. Hypoxia and inflammation. N Engl J Med 2011;364(7): 656–65.
Esteban M, et al. (2014). Acute Coronary Syndrome in the Young: Clinical Characteristics, Risk
Factors and Prognosis , The Open Cardiovascular Medicine Journal, 8, 61-67

Felmeden DC, Blann AD, Lip GY. (2003). Angiogenesis: basic pathophysiology and
implications for disease. Eur Heart J; 24:586-603.

Ferrara, N., Carver-Moore, K., Chen, H., Dowd, M., Lu, L., O’Shea, K.S., Powell-Braxton, L.,
Hillan, K.J., and Moore, M.W. (1996) Heterozygous embryonic le-thality induced by targeted
inactivation of the VEGF gene. Nature 380, 4393442

Fesmire FM, Percy RF, Bardoner JB, Wharton DR, Calhoun FB. (1998). Usefulness of
automated serial 12-lead ECG monitoring during the initial emergency department evaluation of
patients with chest pain. Ann Emerg Med; 31: 3–11.

Fiedler, U, Augustin, Hellmut G. (2006). Angiopoietins : A Link Between Angiogenesis and

Inflammation. Trends in Immunology. 27 : 552-8


Finsen et al. (2003). Increased syndecan expression following myocardial infarction indicates a
role in cardiac remodeling. Physiol Genomics. 16: 301–308

Fisch C, Mandrola JM, Rardon DP. (1997). Electrocardiographic manifestations of dual

atrioventricular node conduction during sinus rhythm. J Am Coll Cardiol; 29: 1015–1022
Gatter KC, Harris AL. (2001). Koukourakis IM and Koukourakis MI: The angiogenic pathway
‘vascular endothelial growth factor/flk-1(KDR)-receptor’ in rheumatoid arthritis and
osteoarthritis. J Pathol 194: 101-108.

Hanahan, Douglas. (1997) Signaling Vascular Morphogenesis and Maintenance. Science. 277 :

Harun S, Alwi I., 2009. Infark Miokard Akut dengan Elevasi ST, dalam: Buku Ajar Ilmu
Pengetahuan Penyakit Dalam Jilid II. Sudoyo A. W, Setryohadi B, Alwi I, Simadibrata M, Setiati
S. Edisi V. Jakarta: Interna Publishing pp. 1757-1764.

Hemingway H, Fitzpatrick NK, Gnani S et al. (2004). Prospective validity of measuring angina
severity with Canadian Cardiovascular Society class: The ACRE study. Can J Cardiol; 20: 305–

Hoberg M, Schmidt EL, Tuerk M, Stark V, Aicher WK and Rudert M. (2009). Induction of
endostatin expression in meniscal fibrochondrocytes by co-culture with endothelial cells. Arch
Orthop Trauma Surg 129: 1137-1143

Hoffmann U, Brady TJ, Muller J. (2003). Cardiology patient page. Use of new imaging
techniques to screen for coronary artery disease. Circulation; 108: e50–e53.

Hojo Y, Ikeda U, Zhu Y, Okada M, Ueno S, Arakawa H, Fujikawa H, Katsuki T and Shimada K.
(2000). Expression of vascular endothelial growth factor in patients with acute myocardial
infarct. J Am Coll Cardiol 35: 968-973

Iba, S. (2016). Glycocalyx Regulates the Intravascular Hemostasis. Juntendo Medical Journal 62
(4): 330-335

Indonesia. Departemen Kesehatan. 2007. Pedoman Pengendalian Penyakit Jantung dan

Pembuluh Darah. Direktorat Pengendalian Penyakit Tidak Menular Dirjen PP dan PL. Jakarta.

Iribarren. C et al. (2011). Circulating Angiopoietins-1 and -2, Angiopoietin Receptor Tie-2 and
Vascular Endothelial Growth Factor-A as Biomarkers of Acute Myocardial Infarction: a
Prospective Nested Case-Control Study. BMC Cardiovascular Disorders. 11(31)

Jiamin N, Xia H, Huaxin Q, Jie Y, Zhiqiang Z, Zeugtang Z. (2016). Correlation between

vascular endothelial growth factor and long-term prognosis in patiens with acute myocardial
infarction. Experimental and Therapeutic Medicine 12: 475-479


Jing Z, Yi-Shuan L, Shu Chien. (2014). Shear Stress-Initiated Signaling and Its Regulation of
Endothelial Function, (Arterioscler Thromb Vasc Biol;34:2191-2198.)

Jones N, Iljin K, Dumont DJ, Alitalo K, (2001). Tie receptors : new modulasatorsof angiogenic
and lymphangiogenic responses. Nat Rev Mol Cell Biol, (2), 257-267
Jons KL, Krous HF, Nadeu J, Blackbourne B, Zielke HR, Gozal D. (2003). ‘vascular endotelial
growth factor in the cerebrospinal fluid of infants who died of sudden infant death syndrome:
evidence for antecedent hypoxia’ Pediatrics ; 111: 358-63

Karkkainen, M.J., Makinen, T. & Alitalo, K. (2002). Lymphatic endothelium: a new frontier of
metastasis research. Nat. Cell Biol. 4, E2–E5.

Katus HA, Looser S, Hallermayer K et al. (1992). Development and in vitro characterization of a
new immunoassay of cardiac troponin T. Clin Chem; 38: 386–393

Kolansky et al, 2009. Acute coronary syndrome: morbidity, mortality, and pharmacoeconomic
burden. American Journal of Managed Care.

Lukasz, A., et al. (2017). Endothelial Glycocalyx Breakdown is Mediated by Angiopoietin-2.

Cardiovascular Research
Lee, Kaeng W., Lip, Gregory, Blann, Andrew D. (2004). Plasma Angiopoietin-1, Angiopoietin-
2, Angiopoietin Receptor Tie-2, and Vascular Endothelial Growth Factor Levels in Acute
Coronary Syndromes. Circulation. 110 : 2355-60

Lee TH, Cook EF, Weisberg M, Sargent RK, Wilson C, Goldman L. (1985). Acute chest pain in
the emergency room. Identification and examination of low-risk patients. Arch Intern Med; 145:

Libby P, et al.(2014). Inflammation and its Resolution as Determinants of Acute Coronary

Syndromes, (Circ Res;114:1867-1879.)

Lim, Hoong S. et al. (2004). Plasma Vascular Endothelial Growth Factor, Angiopoietin-1, and
Angiopoietin-2 in Diabetes. Diabetes Care 27 : 2918-2924.

Loizos, A, et al. (2014). Epidemiology of Acute Coronary Syndrome in the Mediterranean Island
of Cyprus (CYPACS Study, Cyprus Study of Acute Coronary Syndromes), Hellenic J Cardiol;
55: 139-149

Mallat Z, Benamer H, Hugel B et al. (2000). Elevated levels of shed membrane microparticles
with procoagulant potential in the peripheral circulating blood of patients with acute coronary
syndromes. Circulation; 101: 841–843.

Matsudaira K, Maeda K, Okumura N, Yoshikawa D, Morita Y, Mitsuhashi H, Ishii H, Kondo T

and Murohara T. (2012). Nagoya Acute Myocardial Infarction Study (NAMIS) Group: Impact of
low levels of vascular endothelial growth factor after myocardial infarction on 6-month clinical
outcome: Results from the Nagoya Acute Myocardial Infarction Study. Circ J 76: 1509-1516,


Matsumoto T, Ikeda Y, Kunimoto S, Takayama T, Jumabay M, et al. (2010). Low invasive

angiogenic therapy for myocardial infarction by retrograde transplantation of mononuclear cells
expressing the VEGF gene. Int J Cardiol 142: 56-64.

Matsunaga, Toshiro, et al. (2003). Expression of VEGF and Angiopoietins-1 and -2 During
Ischemia-induced Coronary Angiogenesis. Am J Physiol Heart Circ Physiol. 285 : 352-8

McCarthy et al., 1998. The endhotelial receptor tyrosine kinase tie-1 is upregulated by hypoxia
and vascular endhotelial growth factor. Federation of European Biochemical Societies;423. 334-

Mendis et al, (2014). Global target 1: A 25% relative reduction in overall mortality from
cardiovascular disease, cancer, diabetes or chronic respiratory disease. In Armstrong T, editor.
Global Status Report on Non Communicable Disease; p9-20

Miranda, Charlos H., et al. (2016). Evaluation of the Endothelial Glycocalyx Damage in Patients
with Acute Coronary Syndrome. Atherosclerosis 247 : 184-188

Mozaffarian et al, 2015. Heart disease and stroke statistics 2015 update:a report from American
Heart Association. Circulation; 131:e29-2322

Nawawi RA, et al. (2006). Nilai Troponin T (cTnT) Penderita Sindrom Koroner Akut (SKA).
Indonesian Journal of Clinical Pathology and Medical Laboratory, vol 12. No 3

Ostrowski SR et al. (2013). Acute Myocardial Infarction Is Associated With Endothelial

Glycocalyx And Cell Damage And A Parallel Increase In Circulating Catecholamines. Critical
Care 17:R32

Patel, Jeetesh V., et al. (2008). Angiopoietin-2 Levels as a Biomarker of Cardiovascular Risk in
Patients with Hypertension. Annals of Medicine 40:215-222

Peters, Kevin G. (1998). Vascular Endothelial Growth Factor and the Angiopoietins : Working
Together to Build a Better Blood Vessel. American Heart Association

Pichiule, Paola, Chavez, Juan C.,LaManna, Joseph C. (2004). Hypoxic Regulation of

Angiopoietin-2 Expression in Endothelial Cells. The Journal of Biological Chemistry 279 :

Rabelink, T.J., de Zeeuw, D. (2015). The Glycocalyx—Linking Albuminuria with Renal and
Cardiovascular Disease. Natural Reviews Nephrology

Rabenstein, D. 2002. Heparin and heparan sulfate: structure and function. Natural Product
Reports - Royal Society of Chemistry 19, 312–331


Ranjith N, et al. (2011). Risk Factors Associated with Acute Coronary Syndromes in South
African Asian Indian Patients, J Clinic Experiment Cardiol, 2:10

Reitsma, S. 2007. The endothelial glycocalyx: composition, functions, and visualization.

Pflügers Archiv - European Journal of Physiology. 454(3): 345–359
Risalina M. (2012). Patofisiologi Sindrom Koroner Akut, CDK-192 vol.39 no.4

Riskesdas, 2013. Badan Penelitian dan Pengembangan Kesehatan. Kementrian Kesehatan RI.

Saharinen, Pipsa, et al. (2008). Angiopoietins Assemble Distinct Tie2 Signalling Complexes in
Endothelial Cell-Cell and Cell-Matrix Contacts. Nature Cell Biology vol 10

Sarrazin S, et al. (2011). Heparan Sulfate Proteoglycans. Cold Spring Harbour Perspective in
Biology 3: a004952

Savonitto S, Ardissino D, Granger CB et al. (1999). Prognostic value of the admission

electrocardiogram in acute coronary syndromes. JAMA; 281: 707–713

Simons M. (2005). Angiogenesis: where do we stand now? Circulation;111: 1556-1566.

Soeki T, Tamura Y, Shinohara H, Sakabe K, Onose Y and Fukuda N. (2002). Serum hepatocyte
growth factor predicts ventricular remodeling following myocardial infarction. Circ J 66: 1003-

Tousoulis D, Davies G, et al. (2003). Inflammatory and thrombotic mechanism in coronary

atherosclerosis, Heart, Sep;89(9)

Tsigkos, Stelios, Koutsilieris, Micheal, Papapetropoulos, Andreas. (2003). Angiopoietins in

Angiogenesis and Beyond. Ashley Publications

Tsurumi Y, Murohara T, Krasinski K, et al. ( 1997). Reciprocal relation between VEGF and NO
in the regulation of endothelial integrity. Nat Med;3:879-886.

Valenzuale DM, Griffifths JA, Rojas J, Aldrich TH, et al. (1999). Angiopoetin 3 dan 4: diverging
gene counterparts in mice and human. ProcNatiAcad Sci, 96, 1904-1909

Wang Z and Si LY. (2013). Hypoxia-inducible factor-1α and vascular endothelial growth factor
in the cardioprotective effects of intermittent hypoxia in rats. Ups J Med Sci 118: 65-74.

Wong WD et al, 2014. Epidemiological studies of CHD and the evolution of preventive
cardiology. Nature;11:276-89

Ye Zeng. (2016). Endothelial Glycocalyx As A Critical Signalling Platform Integrating The

Extracellular Haemodynamic Forces And Chemical Signaling. Journal of Cellular and Molecular
Medicine 21 (08):1457-1462.


Yin R, Feng J, Chen D and Wu H (2000). Serum levels of vascular endothelial growth factor in
patients with anginapectoris and acute myocardial infarct. Chin Med Sci J 15: 205-209.

Yua X, Soegarb T, Daltonb AC, Robeva DT, Goldgura Y, Rajashankarc KR, et al. (2013).
Structural basis for angiopoetin-1 mediated signaling initiation. PNAS, 110, 7205-7210.